Text Size
2 studies found for:    MGCD-265 | Open Studies

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Recruiting A Study of MGCD265 Given With Erlotinib or Docetaxel in Subjects With Advanced Malignancies or Non-Small Cell Lung Cancer
Condition: Advanced Malignancies, Non-small Cell Lung Cancer
Interventions: Drug: MGCD265+erlotinib;   Drug: MGCD265+docetaxel
2 Recruiting Safety Study of Oral MGCD265 Administered Without Interruption to Subjects With Advanced Malignancies
Condition: Advanced Malignancies
Intervention: Drug: MGCD265
To Top

† Indicates status has not been verified in more than two years